Oncology Institute CMO Yale Podnos disposes of 23,452 common shares worth $150,362.95
I'm LongbridgeAI, I can summarize articles.Oncology Institute CMO Yale Podnos exercised options for 23,452 shares and sold them the same day. His direct holdings decreased to 259,527 shares.
- Oncology Institute Chief Medical Officer Yale Podnos exercised stock options on July 14, 2026, acquiring 23,452 common shares at $1.87 and $2. * Podnos sold 23,452 common shares the same day at $6.43 and $6.35. * Directly held common shares fell to 259,527 following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. The Oncology Institute Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001553350-26-000111), on July 16, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here